BTG Regulatory News (BTG)

BTG to present at the UBS Global Life Sciences Conference

London, UK, 17 September 2012: BTG plc (LSE: BTG), the specialist healthcare company today announces that Andy Burrows, Director of Investor Relations will be presenting an overview of the company and its strategic objectives at the UBS Global Life Sciences Conference in New York on Wednesday 19 September at 9.30am local (EDT) time.

For those unable to attend the presentation, a PDF will be accessible in the following area of BTG's corporate website:

http://www.btgplc.com/investors/results-and-presentations

For further information please contact:

BTG

Andy Burrows, Director of Investor Relations

+44 (0)20 7575 1741; Mobile: +44 (0)7990 530605

Rolf Soderstrom, Chief Financial Officer+44 (0)20 7575 0000

FTI Consulting

Ben Atwell

+44 (0)20 7269 7242

About BTG

BTG is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The company has diversified revenues from sales of its own marketed products and from royalties on partnered products, and is seeking to acquire new programmes and products to develop and market to specialist physicians. For further information about BTG please visit our website at www.btgplc.com.